-
-
Call more information
660-596-2224 -
Authors: Motov S et al., Am J Emerg Med 2017 Mar 3; Neuropsychiatric side effects were more common with intravenous push administration, but does it matter? At intravenous (IV) doses of 0.1–0.3 mg/kg, ketamine is a safe and effective analgesic. Adverse effects are minimal and include sedation and a feeling of disconnection from reality. Investigators compared the effectiveness […]
Read MoreBy Kelly Young Edited by Susan Sadoughi, MD, and Richard Saitz, MD, MPH, FACP, DFASAM The American Heart Association and the American College of Cardiology have updated their guidelines for managing valvular heart disease. The new guidance appears in Circulation. Here are a few of the changes since the 2014 guidelines: Antibiotic prophylaxis for certain dental work is […]
Read MoreBy Amy Orciari Herman Edited by Lorenzo Di Francesco, MD, FACP, FHM Concurrent use of opioids and benzodiazepines nearly doubled from 2001 through 2013, leading to an increase in opioid overdoses, suggests a retrospective study in The BMJ. Using a large U.S. health claims database, researchers studied some 315,000 adults who filled at least one prescription for […]
Read MoreBy Christine Rhodes Interview with Jennifer Baima, MD Studies show there is no one-size-fits-all approach to rehabilitation from cancer surgery. Each type of cancer requires a different approach to achieve adherence, and lessen pain while working to restore physical function and other post-treatment challenges. Physical and occupational therapy are important components of recovery for many cancer […]
Read MoreBy Thomas G. Ciccone Interview with Tor D. Wager, PhD Researchers from the University of Colorado have mapped the brain in people with fibromyalgia as they responded to painful stimuli. These images offer pain practitioners new insights into the neurophysiology of this condition. Historically, fibromyalgia (FM) lacks a definitive explanation for its underlying mechanisms of action,1 and has […]
Read More